Design, synthesis and biological evaluation of a new class of 7H-pyrrolo[2,3-d]pyrimidine derivatives as Mps1 inhibitors for the treatment of breast cancer-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of a new class of 7H-pyrrolo[2,3-d]pyrimidine derivatives as Mps1 inhibitors for the treatment of breast cancer

Published:2023-01 Issue: Volume:245 Page:114887
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Li Xinyue,Wei Wei,Tao Longyue,Zeng Jun,Zhu Yongxia,Yang Tianqiong,Wang Qiwei,Tang Minhai,Liu Zhihao,Yu Luoting^ORCID

Funder

Natural Science Foundation of Sichuan Province

National Natural Science Foundation of China

Key Science and Technology Program of Shaanxi Province

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference36 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021

2. Chemoresistance mechanisms of breast cancer and their countermeasures;Ji;Biomed. Pharmacother.,2019

3. Direct interactions of mitotic arrest deficient 1 (MAD1) domains with each other and MAD2 conformers are required for mitotic checkpoint signaling;Ji;J. Biol. Chem.,2018

4. Mps1 activation loop autophosphorylation enhances kinase activity;Mattison;J. Biol. Chem.,2007

5. Phosphoregulation of human Mps1 kinase;Tyler;Biochem. J.,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments of Pyrrolo[2,3-d]pyrimidines with Pharmaceutical Potential;Current Organic Chemistry;2024-09

2. Design and discovery of monopolar spindle kinase 1 (MPS1/TTK) inhibitors by computational approaches;Medicinal Chemistry Research;2024-07-24

3. Hijacking monopolar spindle 1 (MPS1) for various cancer types by small molecular inhibitors: Deep insights from a decade of research and patents;European Journal of Medicinal Chemistry;2024-07

4. Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential;Archiv der Pharmazie;2024-05-16

5. Development of MPS1 Inhibitors: Recent Advances and Perspectives;Journal of Medicinal Chemistry;2023-12-14